Spago Nanomedical AB (publ) SPAGO.ST · SEK

Its shares trade on Nasdaq Stockholm under the ticker SPAGO.ST. It has been listed since 15 January 2013. In the fiscal year to 31 December 2025, it reported revenue of SEK 437,000 and a net loss of SEK 26.6m. At that date it held total assets of SEK 36.7m and shareholders' equity of SEK 30.7m.

Spagpo Nanomedical AB engages in the provision of research and development within nanomedicine. The company is headquartered in Lund, Skane. The company went IPO on 2013-01-15. The company specialized in the areas of contrast agents and nanoscale life science research. The firm is involved in three projects: Spago Pix, a nanomaterial developed for use as a cancer selective contrast agent for Magnetic Resonance Imaging (MRI); the therapeutic project Tumorad, using nanoparticles loaded with radionuclides for selective treatment of cancers, which are unsuitable for surgery or external radiation; and Archaea Platin, aimed at delivering of chemotherapeutic substance cisplatin selectively to tumors in order to reduce side effects on healthy tissue. The firm's technology comprises a technology platform IonXgel, which is a nano-sized biocompatible material consisting of polar polymers; a protein-based drug delivery platform, ProtRc; and 3PEG, a platform which enables attachment of polyethylene glycol (PEG) derivatives to small molecules (PEGylation).

Figures and description from our data supplier, not checked against the company's own report.

• Mats Hansen, PhDChief Executive Officer, since 2015
• Hanna OlssonChief Financial Officer, since 2019
• Oskar Axelsson, PhDChief Scientific Officer & Vice President, since 2007
• Paul HargreavesChief Development Officer, since 2022
• Tove Sivik SonneHead-Development, since 2013
• Eugen Steiner, MD, PhDChairman, since 2019
• Nicklas WesterholmIndependent Director, since 2019
• Sten Nilsson, MD, PhDIndependent Director, since 2013
• Peter Leander, MD, PhDIndependent Director, since 2012
• Kari GrønåsIndependent Director, since 2018

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.